Kyowa Hakko Kirin Co. Ltd. | |
Stock Exchange | Other OTC |
EPS |
$0.67 |
Market Cap |
$9.53 B |
Shares Outstanding |
576.48 M |
Public Float |
- |
Kyowa Hakko Kirin Co. Ltd. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
576.48 M |
Public Float |
- |
Kyowa Hakko Kirin Co. Ltd. | |
Stock Exchange | Tokyo Stock Exchange |
EPS |
JPY74.09 |
Market Cap |
JPY1.03 T |
Shares Outstanding |
540 M |
Public Float |
227.24 M |
Address |
Otemachi Financial City Grand Cube Tokyo Tokyo 100 Japan |
Employees | - |
Website | http://www.kyowa-kirin.co.jp |
Updated | 07/08/2019 |
Kyowa Hakko Kirin Co., Ltd. engages in the manufacture and sale of medical and pharmaceutical products. It operates through the Pharmaceuticals and Bio-Chemicals segments. The Pharmaceuticals segment deals with the research, development, production, and sale of in vitro diagnostic reagents and ethical drugs concerning renal anemia, leukemia, cancer, allergies, and hypertension. |